全文获取类型
收费全文 | 1574篇 |
免费 | 96篇 |
国内免费 | 72篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 37篇 |
妇产科学 | 210篇 |
基础医学 | 230篇 |
口腔科学 | 17篇 |
临床医学 | 151篇 |
内科学 | 178篇 |
皮肤病学 | 19篇 |
神经病学 | 101篇 |
特种医学 | 159篇 |
外科学 | 179篇 |
综合类 | 90篇 |
预防医学 | 62篇 |
眼科学 | 79篇 |
药学 | 93篇 |
中国医学 | 2篇 |
肿瘤学 | 126篇 |
出版年
2022年 | 15篇 |
2021年 | 19篇 |
2020年 | 17篇 |
2019年 | 19篇 |
2018年 | 19篇 |
2017年 | 13篇 |
2016年 | 11篇 |
2015年 | 26篇 |
2014年 | 30篇 |
2013年 | 39篇 |
2012年 | 57篇 |
2011年 | 57篇 |
2010年 | 74篇 |
2009年 | 72篇 |
2008年 | 79篇 |
2007年 | 128篇 |
2006年 | 70篇 |
2005年 | 49篇 |
2004年 | 72篇 |
2003年 | 50篇 |
2002年 | 47篇 |
2001年 | 48篇 |
2000年 | 43篇 |
1999年 | 44篇 |
1998年 | 36篇 |
1997年 | 44篇 |
1996年 | 47篇 |
1995年 | 35篇 |
1994年 | 25篇 |
1993年 | 25篇 |
1992年 | 38篇 |
1991年 | 46篇 |
1990年 | 39篇 |
1989年 | 40篇 |
1988年 | 39篇 |
1987年 | 30篇 |
1986年 | 28篇 |
1985年 | 27篇 |
1984年 | 16篇 |
1983年 | 18篇 |
1982年 | 16篇 |
1981年 | 10篇 |
1980年 | 10篇 |
1979年 | 8篇 |
1978年 | 10篇 |
1977年 | 14篇 |
1976年 | 12篇 |
1975年 | 9篇 |
1972年 | 5篇 |
1971年 | 3篇 |
排序方式: 共有1742条查询结果,搜索用时 15 毫秒
31.
Tom De Beule T Boulanger S Heye WJ van Rooij WH van Zwam L Stockx 《Interventional neuroradiology》2021,27(1):51
Background and purposeFlow diverters are increasingly used to treat intracranial aneurysms. We report the safety and efficacy of the p64 flow diverter, a resheathable and detachable device for intracranial aneurysms.Materials and methodsWe retrospectively reviewed 108 patients with 109 aneurysms treated with the p64 between March 2014 and July 2019. There were 87 women and 21 men, mean age 57 years. Of 109 aneurysms, 74 were discovered incidentally, 12 were symptomatic, 18 were previously treated, and five were ruptured dissection aneurysms. A total of 10 aneurysms were located in the posterior circulation. The mean aneurysm or remnant size was 8.1 mm.ResultsHemorrhage by perforation with the distal guidewire occurred in two patients with permanent neurological deficits in one. In one patient, acute in-stent occlusion caused infarction with a permanent deficit. Permanent morbidity was 1.9% (2 of 108, 95%CI 0.1–6.9%); there was no mortality. During follow-up, three in-stent occlusions occurred, all asymptomatic. There were no delayed hemorrhagic complications. At six months, 77 of 96 aneurysms (80.2%) were completely occluded, and at last follow-up, this increased to 93 of 96 aneurysms (96.9%). In-stent stenosis at any degree occurred in 11 patients, progressing to asymptomatic complete occlusion in one. In the other patients, stenosis resolved or improved at further follow-up.ConclusionThe p64 offers an effective and safe treatment option. Aneurysm occlusion rate was 97% at last follow-up, mostly achieved with a single device. There were no delayed hemorrhagic complications. Delayed in-stent stenosis infrequently progresses to occlusion but remains a matter of concern. 相似文献
32.
33.
Chang SY Yong TF Yu CY Liang MC Pletnikova O Troncoso J Burgunder JM Soong TW 《Neuroscience》2007,145(3):1026-1036
Ca(v)2.1 Ca(2+) channels (P/Q-type), which participate in various key roles in the CNS by mediating calcium influx, are extensively spliced. One of its alternatively-spliced exons is 37, which forms part of the EF hand. The expression of exon 37a (EFa form), but not exon 37b (EFb form), confers the channel an activity-dependent enhancement of channel opening known as Ca(2+)-dependent facilitation (CDF). In this study, we analyzed the trend of EF hand splice variant distributions in mouse, rat and human brain tissues. We observed a developmental switch in rodents, as well as an age and gender bias in human brain tissues, suggestive of a possible role of these EF hand splice variants in neurophysiological specialization. A parallel study performed on rodent brains showed that the data drawn from human and rodent tissues may not necessarily correlate in the process of aging. 相似文献
34.
35.
36.
Li-Ching Lee Yu-Ting Weng Yih-Ru Wu Bing-Wen Soong Yung-Che Tseng Chiung-Mei Chen Guey-Jen Lee-Chen 《Journal of neural transmission (Vienna, Austria : 1996)》2014,121(6):601-610
Spinocerebellar ataxia type 17 (SCA17) is caused by CAG repeat expansion in the TATA-box binding protein gene. Studies of several polyglutamine (polyQ) expansion diseases have suggested that the expanded polyQ proteins misfold and induce oxidative stress to contribute to cell death. Substantial deficits in peripheral tissues including lymphocytes have been shown and these peripheral abnormalities could also be found in neurons possessing polyQ disease proteins. In this study, we used a lymphoblastoid cell model to investigate the functional implication of SCA17 expanded alleles and assess the potential therapeutic strategies that may ameliorate the effects of expanded polyQ. Proteomics studies of patient/control pairs including two-dimensional (2-D) gel electrophoresis, mass spectrometry and immunoblotting were conducted. A total of 8 proteins with reduced expression changes greater than 1.3-fold were identified, including previously reported HSPA5 and HSPA8. Among 6 proteins further semi-quantified by immunoblotting and real-time PCR, the reduced expression of HYOU1, PDIA3, P4HB, NQO1 and HMOX1 was confirmed. Treatment with resveratrol and genipin up-regulated NQO1 and HMOX1 expression and reduced oxidative stress in patients’ lymphoblastoid cells. The results illustrate downregulation of proteins involved in the endoplasmic reticulum stress response (HYOU1, HSPA5, PDIA3, and P4HB) and Nrf2-ARE signaling (NQO1 and HMOX1) in SCA17 lymphoblastoid cells. Compounds increasing anti-oxidative activity such as resveratrol and genipin may serve as a potential therapeutic strategy for SCA17. 相似文献
37.
Jonathan D. Cherry Soong Ho Kim Thor D. Stein Morgan J. Pothast Raymond Nicks Gaoyuan Meng Bertrand R. Huber Jesse Mez Michael L. Alosco Yorghos Tripodis Kurt Farrell Victor E. Alvarez Ann C. McKee John F. Crary 《Brain pathology (Zurich, Switzerland)》2020,30(5):913-925
Chronic traumatic encephalopathy (CTE) is a neurodegenerative tauopathy characterized by accumulation of hyperphosphorylated tau (p‐tau) in perivascular aggregates in neurons and glia at the depths of neocortical sulci and progresses to diffuse neocortical, allocortical and brainstem structures. The strongest risk factor is exposure to repetitive head impacts acquired most commonly through contact sports and military service. Given that CTE can only be definitively diagnosed after death, a better understanding of the cellular and molecular changes in CTE brains may lead to identification of mechanisms that could be used for novel biomarkers, monitoring progression or therapeutic development. Disruption of alternative pre‐mRNA splicing of tau mRNA plays a pathogenic role in tauopathy, with multiple characteristic patterns of isoform accumulation varying among tauopathies. Limited data are available on CTE, particularly at early stages. Using biochemical and histological approaches, we performed a detailed characterization of tau isoform signatures in post‐mortem human brain tissue from individuals with a range of CTE stages (n = 99). In immunoblot analyses, severity was associated with decreased total monomeric tau and increased total oligomeric tau. Immunoblot with isoform‐specific antisera revealed that oligomeric tau with three and four microtubule binding domain repeats (3R and 4R) also increased with CTE severity. Similarly, immunohistochemical studies revealed p‐tau accumulation consisting of both 3R and 4R in perivascular lesions. When the ratio of 4R:3R was analyzed, there was mixed expression throughout CTE stages, although 4R predominated in early CTE stages (I‐II), a 3R shift was observed in later stages (III‐IV). While neurons were found to contain both 3R and 4R, astrocytes only contained 4R. These 4R‐positive cells were exclusively neuronal at early stages. Overall, these findings demonstrate that CTE is a mixed 4R/3R tauopathy. Furthermore, histologic analysis reveals a progressive shift in tau isoforms that correlates with CTE stage and extent of neuronal pathology. 相似文献
38.
Chiu Hsu-Huai Hsaio Cheng-Tsung Tsai Yu-Shuen Liao Yi-Chu Lee Yi-Chung Soong Bing-Wen 《Cerebellum (London, England)》2020,19(4):544-549
The Cerebellum - Mutations in STUB1 have been identified to cause autosomal recessive spinocerebellar ataxia type 16 (SCAR16), also named as Gordon Holmes syndrome, which is characterized by... 相似文献
39.
Demichelis F Setlur SR Banerjee S Chakravarty D Chen JY Chen CX Huang J Beltran H Oldridge DA Kitabayashi N Stenzel B Schaefer G Horninger W Bektic J Chinnaiyan AM Goldenberg S Siddiqui J Regan MM Kearney M Soong TD Rickman DS Elemento O Wei JT Scherr DS Sanda MA Bartsch G Lee C Klocker H Rubin MA 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(17):6686-6691
40.
Barry J. Iacopetta Richie Soong Anthony K. House Richard Hamelin 《The Journal of pathology》1999,187(4):428-432
The replication error phenotype (RER+) represents an important new form of genetic alteration characterized by widespread instability in repetitive nucleotide sequences. The aim of this study was to compare the features of RER+ gastric tumours with those of RER+ colonic tumours. RER status was determined by analysis of size alterations in the BAT-26 mononucleotide repeat microsatellite. Twelve of 121 (10 per cent) gastric carcinomas from a low-incidence region were found to be RER+. BAT-26 instability was associated with tumours showing an absence of nodal invasion (p = 0·009) and with a trend for improved prognosis. These tumours were more frequent in older, female patients. Frameshift mutations in mononucleotide repeat sequences within the transforming growth factor-β receptor II (RII), insulin-like growth factor II receptor (IGFIIR), and BAX genes were observed in 83, 33, and 25 per cent, respectively, of RER+ tumours. Only 1/12 (8 per cent) RER+ tumours contained a p53 gene mutation compared with 29/109 (27 per cent) RER− tumours. RER+ gastric carcinomas therefore share several important features with RER+ colonic tumours, including less frequent nodal invasion, improved prognosis, a similar frequency of mutation in growth control genes containing repetitive nucleotide sequences, and a low frequency of mutation of the p53 tumour suppressor gene. Copyright © 1999 John Wiley & Sons, Ltd. 相似文献